STEM at CBER

preview_player
Показать описание
CBER conducts scientific research that is integral to the Center's mission of regulating biologic products as well as its public health portfolio. The research program encompasses biomedical science, technology, engineering, and math (STEM) and offers training and fellowship opportunities.
  1. U.S. Food and Drug Administration
Рекомендации по теме
STEM at CBER 0:04:26

STEM at CBER

WSCS 2018 - 1:22:30

WSCS 2018 - Day 1 - FDA CBER Overview and Accelerated Pathways in Regenerative Medicine

Stem Cells & 0:32:31

Stem Cells & FDA Oversight

Inside Genome Editing 0:25:18

Inside Genome Editing with CBER's Dr. Peter Marks

SEND for CBER, 0:56:35

SEND for CBER, What You Need to Know

FDA appears to 0:08:42

FDA appears to be revisiting the laws around stem cell therapy

Preview: CBER Director 0:00:38

Preview: CBER Director Peter Marks' Commitment to Gene Therapy at ARM's 2020 Meeting on th...

Importing and Exporting 0:29:46

Importing and Exporting CBER Regulated Products

Landscape of OA 0:09:28

Landscape of OA Drug and Biologic Development, CBER Regulatory Perspective | Elizabeth Hart

FDA’s Efforts to 0:16:25

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FDA | NIH: 1:05:05

FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA – CBER Segment

Webinar: First-in-Human Trials 0:20:43

Webinar: First-in-Human Trials of Stem-Cell Based Therapies - John Hyde

Decoding FDA's Standards 0:03:24

Decoding FDA's Standards for Regenerative Medicine

FDA sets path 0:10:20

FDA sets path for stem cell therapies

Updates on FDA’s 0:32:47

Updates on FDA’s Efforts to Accelerated Advances in Cell and Gene Therapy

Julie Cerrone FDA 0:04:59

Julie Cerrone FDA Stem Cell Hearing Testimony

Stem Cell Therapies: 1:29:58

Stem Cell Therapies: Hype, Hope and Evidence-based Decisions

NHLBI Small Biz 0:53:54

NHLBI Small Biz Hangout: Biologics Regulation Overview

How Entrepreneurship Can 0:04:14

How Entrepreneurship Can Be a Force for Good | NYU Shanghai CBER

Featured Fireside Chat: 1:10:39

Featured Fireside Chat: FDA Perspective

Fireside Chat: FDA 0:38:22

Fireside Chat: FDA Perspective

AASCP NOV 7-8 0:05:14

AASCP NOV 7-8 Virtual Conference - Peter Marks, M.D., Ph.D., CBER Commissioner, FDA

Cell & Gene 1:10:06

Cell & Gene Therapy Products 2022 Keynote: Peter Marks, CBER, FDA

FDA’s Efforts to 0:20:23

FDA’s Efforts to Facilitate the Development of Safe & Effective Regenerative Medicine Products